newsfilter
← Latest News
ACCESS Newswire·

Altamira Therapeutics Provides Business Update, Reports FY 2022 Financial Results

Management will host an investor conference call today, May 16th, at 8 a.m. EasternCompany is advancing OligoPhore™ / SemaPhore™ platform for extrahepatic RNA delivery and efficient endosomal release; expects